SystemDomain Chicago based IT firm made to Top 25 Cyber Security Companies 2018 by CIO Applications

CIO Applications had shortlisted SystemDomain as "Top 25 Cyber Security Companies 2018"

CHICAGO, IL, USA, February 22, 2018 /EINPresswire.com/ — SystemDomain, Inc, a Chicago based leading global information technology and consulting services company, today announced that SystemDomain made to the list of "Top 25 Cyber Security Companies 2018". SystemDomain had been selected as Top 25 Cyber Security Companies 2018 based upon demonstrated great capabilities and growth trajectory. SystemDomain has been shortlisted to be featured in 2nd annual edition on Cyber Security of CIO Applications.

"We feel very proud to know that SystemDomain had been shortlisted as "Top 25 Cyber Security Companies 2018". It is an honor to be recognized by CIOApplications", said Shubhi Garg, President, SystemDomain, Inc, "We will continue to build upon our promise to provide best-in-class solutions and services."

SystemDomain provides consulting to implement and integrate end to end Cyber Security solutions to address the cyber vulnerabilities and threats across the enterprises i.e. Information Systems, Network, Database, Physical Access, Access Control and Management, Cloud, Mobile. SystemDomain's solutions and professional services help protect the customers, shareholders and employees of the corporations in cost effective and efficient manner. SystemDomain also provides the business intelligence for proactive monitoring of Critical Cyber Assets.

SystemDomain offers state-of-the-art solutions in Risk Management such as: Threat Detection & Response, Cyber Security Operations, Security & Behavioral Analytics, Fraud Intelligence Services, Governance Risk & Compliance, IT & Security Risk Management, Regulatory & Corporate Compliance Management, Audit Management, Business Resiliency, Third Party Governance, Public Sector Solutions. SystemDomain’s Cyber Security and Risk Consulting practice is rapidly accelerating and implementing the state-of-the-art solutions for multiple use cases.

Additional Key award wins and industry accolades for SystemDomain:
SystemDomain had been ranked as ‘Top 20 Most promising Cyber Security Solution Provider 2017' by “Silicon India”
SystemDomain Inc. had been selected as one of Diversity Business.com’s (now OMNIKAL) OMNI500 Top Businesses for 2017.
Gold Award for 2018 as the Fastest Growing Cyber Security firm by Cyber Security Excellence Awards

Cyber Security, Digital, Cloud, and Data Analytics are its primary focus areas providing unparalleled solutions and services to build the business around our comprehensive products and services portfolio. The strategic partnerships allow SystemDomain to offer the products and services at very competitive pricing to our clients. Our partnership empowers with exceptional resources that distinguish our offering from the competition.

About SystemDomain Inc.

SystemDomain is an IT Consulting firm based in IL with focus in Cyber Security & Risk Management, Digital, Cloud, Data Analytics and Professional Services (such as Enterprise Architecture, Database, Network Management, ERP, CRM, Cloud and Digital Transformation). SystemDomain strives to connect with their customers, clients, and partners with an unbeatable portfolio of solutions to leverage critical trends such as big data & analytics, social business and security. SDI has offshore software development and support centers for clients who are interested in cost-effective services.

Our determination for customer satisfaction and delivering the efficient & cost-effective solutions are our secrets of success.
(http://www.systemdomaininc.com)

About CIOApplications:
CIO Applications creates a modern community of CIO's and technology leaders, including other representatives of tech vendors. These vendors can come to understand what kind of expertise CIO's can provide, gain in depth knowledge of the needs of the CIO's and connect with them. It provides a platform for technology professionals, interested in business aspects of using technology for the enterprises in specific industries, to share their insights, experiences, advice with their peers involved in leveraging technology for their businesses. It provides a unique learn-from-peer approach for evaluating and using technology from a business perspective. It connects the vendors with the CIO's so as to engage and showcase their innovative solutions and services for the enterprises.
https://www.cioapplications.com/about-us/

For more information:

Media Relations
SystemDomain, Inc.
+1 (630) 544 4180
email us here


Source: EIN Presswire

Healthcare Giants Promote Cardiac Awareness Alongside Donna Karan in New York City

Jacqeuline Leviton, Urban Zen Integrative Therapist at St. James Rehabilitation and Healthcare Center in Long Island, providing a personal experience for a VIP guest.

Dr. Christopher Glenn, Medical Director of The Riverside Premier Rehabilitation and Healing Center in New York City sharing how Urban Zen has increased patient satisfaction at the center

Donna Karan alongside executive leadership of CareRite Centers during the Heart Health Awareness Symposium at Urban Zen’s flagship in New York City.

Donna Karan and CareRite Centers Promote Cardiac Wellness alongside New York City's Highest Ranking Physicians and Executives

NEW YORK, NEW YORK , UNITED STATES OF AMERICA , February 22, 2018 /EINPresswire.com/ — Media Kit accessible through link below:

http://careritecenters.com/raising-awareness-heart-health-month/

Global Healthcare Giants Raise Awareness For Cardiac Health in New York City

NEW YORK – CareRite Centers, LLC, for rehabilitation and nursing was proud to welcome, alongside Donna Karan, New York’s leading healthcare executives, physicians, and caregivers to the Urban Zen flagship in New York City in observance of National Heart Health Month.

In a movement to raise awareness for cardiac health and wellness globally, CareRite Centers and Urban Zen shared with leading clinical experts the positive impact of self-care and integrative healing modalities in Western medicine. The evening was headlined by New York’s Donna Karan, as she shared the mission of Urban Zen Integrative Therapy in partnership with CareRite Centers. “Marrying the Urban Zen modalities and therapists with CareRite’s luxury, patient-centered approach has enormous potential to create the optimal healing environment, focusing on the individual and tailoring the care based on individual needs,” shared Karan.

CareRite Centers has welcomed Urban Zen Integrative Therapy to ten skilled nursing centers across the nation to date, ensuing a nearly 11% increase in overall patient satisfaction, and over a 14% increase in patient reported pain relief without the use of medication. Dr. Christopher Glenn, Medical Director of The Riverside Premier Rehabilitation and Healing Center in New York City, noted the opportunity of integrative therapy in Western medical practice. In medicine, you must “increase your capacity to love,” shared Glenn.

The Urban Zen and CareRite Centers partnership has successfully provided over 9,000 experiences to those under the care of CareRite team members, including that of private experiences for employees, patients and their loved ones, while also serving as locations for free Urban Zen Integrative Therapy community classes for professionals and family members.

“The philosophy of CareRite Centers has a deep-rooted commitment to patient satisfaction and customer service, serving as the foundational underpinning for all that we do, and provide for those under our care. Our mission is to provide our patients, our employees, and of course our families with an experience unlike any other,” shared Ashley Romano, National Director of Patient Experience/Research Development for CareRite Centers.

CareRite Centers, LLC is a dynamic healthcare organization that services the needs of short term
rehabilitation, skilled nursing, and long term care for thousands of patients across the nation. With a strong commitment to customer service, innovation, and philanthropy, the organization is currently represented in centers across New York, New Jersey, Pennsylvania, Ohio, Tennessee, and Florida.

Ashley Romano
CareRite Centers
631-617-7785
email us here


Source: EIN Presswire

New Utah Valley Clinic in the Sorenson Legacy Tower at Intermountain Utah Valley Hospital Now Open

SALT LAKE CITY, UTAH, USA, February 22, 2018 /EINPresswire.com/ — The new Utah Valley Clinic in the Sorenson Legacy Tower at Intermountain Utah Valley Hospital is now open. The nine-story building, named for a significant gift from the Sorenson Legacy Foundation, is the first phase of Utah Valley’s $430 million hospital replacement project to reach completion. The remaining phase, a 12-story patient tower, is expected to be completed in December.

Utah Valley Clinic houses both hospital outpatient services and Intermountain Medical Group physician clinics. The new Cancer Center brings radiation and medical oncology services together, which have been housed on opposite sides of the hospital. The Education Center can host more than 600 people, but also divides into smaller meeting rooms. It also features two simulation labs – one designed after an operating room and one designed after the patient rooms that will be in the new patient tower.

The LiVe Well Center on the clinic’s fourth floor is a new service to the hospital that can help people at any stage in their wellness journey. The classes and programs at the center provide hands-on support to help a person improve his or her fitness level or nutrition habits. The center also features a new demonstration kitchen where Intermountain chefs and dietitians will emphasize healthy eating and provide hands-on instruction to class members.

“We’re always looking to improve each patient’s experience at our hospital and having these services all in one building will allow for a more convenient visit,” says Kevin Brooks, Utah Valley administrator. “We’re extremely grateful to the Sorenson Legacy Foundation and the other generous donors who contributed to support this phase of our replacement project.”

Other services in the new clinic include:
• Utah Valley InstaCare
• Heart & Lung
• Dermatology
• Cardiac Rehabilitation
• Maternal Fetal Medicine
• Diabetes Management
• Speech, Hearing & Balance
• IV Therapy
• Allergy & Asthma
• Ear, Nose & Throat
• Neurology
• Vascular
• Senior Care
• Internal Medicine
• Pharmacy
• Pediatric specialists
• Stroke
• Palliative Care
• Urology

In addition to the Sorenson Legacy Foundation, many other donors contributed to make the Utah Valley Clinic completion possible. These include:
• The Blake and Nancy Roney Family in memory of Jeane Roney
• Revere Health
• The Steven J. and Kalleen Lund Family
• The Ashton Family Foundation
• Jacobsen Construction Company
• The Dan and Paula Shaw Family in honor of Don and May Shaw
• The Merrill and Marie Gappmayer Family
• Stephen and Christine Neeleman and HealthEquity, Inc.
• TJ Blair, MD, PhD, in memory of Lorie Larsen Blair
• Norma Rhode
• Utah Valley Eye Center
• The Henry and Renee Heilesen Family
• The Kevin and Melissa Brooks Family
• The Joey and Vicki Hansen Family
• Mike Mann
• Wilkinson Electric, Inc.

Intermountain Healthcare is a not-for-profit health system based in Salt Lake City. Recognized for its excellent clinical care and low costs, Intermountain strives to help people live the healthiest lives possible. For more information, visit www.intermountainhealthcare.org

Daron Cowley
Intermountain Healthcare
801-442-2834
email us here


Source: EIN Presswire

Cary Skin Center Celebrates 20 Years Of Skin Cancer Treatment In North Carolina

Cary Skin Center Physicians

Practice Continues Growth Expansion In the Pinehurst, N.C. Area

Our Mohs surgeons and staff focus on providing the most advanced surgical treatments and the practice’s doctors are extensively trained in surgical reconstruction.”

— Robert E. Clark, MD, PhD

PINEHURST, NORTH CAROLINA, USA, February 22, 2018 /EINPresswire.com/ — This month The Cary Skin Center is celebrating 20 years as a medical practice. The practice – one of the North Carolina’s largest Mohs surgery groups – is still growing and expanding. The practice added two more physicians and a physician assistant to its staff and added additional staff to their office in Pinehurst, N.C.
The practice is celebrating its 20th year with a huge gala event for the referring physician colleagues on Wednesday, March 14 from 5:30 to 7:30 pm at Cary Skin Center Pinehurst located at 5 Regional Cir Suite C, Pinehurst, NC 28374. The practice will be serving sumptuous hors d’oeuvres and marvelous wines for their physician visitors enjoyment and the opportunity to meet the two exceptionally trained and experienced Mohs surgeons that joined Cary Skin Center this year as well as providing hostess guided tours of our newly up-fitted facility.
The Cary Skin Center began in 1998 when Dr. Clark established the Cary Skin Center, a state-of-the-art outpatient surgical center specializing in Mohs Micrographic Surgery for the removal of skin cancer. Dr. Flynn joined the Cary Skin Center in 2001 and together they have successfully treated countless patients in the Triangle and surrounding areas. We now welcome Dr. Ayli and Dr. Ingraffea to the clinical staff at Cary Skin Center. Because Mohs surgery is a highly complex and sophisticated surgical method, it requires extensive training. Our doctors have completed intensive training programs, including complex surgical cases and advanced reconstructions, to become Fellows of the American College of Mohs Surgery. In addition, they offer over 62 years of combined Mohs surgery experience.
“The physicians and staff of Cary Skin Center seek to provide the highest quality of healthcare to our patients. We pledge compassionate, timely, and confidential care,” said Dr. Clark.
“The face of medicine is changing all the time,” said Dr. Clark. “Our Mohs surgeons and staff focus on providing the most advanced surgical treatments and the practice’s doctors are extensively trained in surgical reconstruction. This includes basic closures, and more complicated skin flaps and skin grafts. They perform hundreds of these procedures each year. The goal is to provide the best possible cosmetic result after the removal of skin cancer.”
The Cary Skin Center is a skin cancer treatment center. Mohs micrographic surgery was developed by Frederic E. Mohs, MD over 50 years ago, and it continues to be the most advanced and effective treatment procedure available for skin cancer. The goal of the procedure is to remove the skin cancer completely while minimizing the removal of uninvolved healthy tissue. It is performed under local anesthesia on an out-patient basis.
For decades, Mohs micrographic surgery has proven effective in removing skin cancer by combining the surgical removal of cancer with the immediate microscopic examination of the tumor and underlying diseased tissue. This process allows the surgeon to see beyond the visible disease and precisely identify and remove the entire tumor. Mohs surgery traces the path of the tumor cells using two key tools: a precise map of the surgical site and a microscope.
The Cary Skin Center is conveniently located on the corner NC Highway 55 and High House/Green Level Road in Cary, NC. Our Pinehurst office is located at 5 Regional Circle, Suite C in Pinehurst, NC. We offer free on-site parking with easily accessible patient drop-off, Wi-Fi and comfortable patient lobby.
For more information about Cary Skin Center, visit www.caryskincenter.com, or call 919-363-7546.

Parker Eales
Cary Skin Center
919-303-4053
email us here

SKIN CANCER – PINEHURST NC


Source: EIN Presswire

Animal Nutrition Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2023

PUNE, MAHARASHTRA, INDIA, February 22, 2018 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Animal Nutrition Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Animal Nutrition Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Global and Regional Animal Nutrition market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

By Company
BASF
Cargill
Royal DSM
Nutreco
Evonik Industries
Novozymes
DuPont
Dow Chemical
Alltech
Kemin Industries
Archer-Daniels-Midland
Adisseo France

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2641788-global-and-regional-animal-nutrition-market-research-report-2017

Market Segment as follows:
By Region
Asia-Pacific
North America
Europe
South America
Middle East & Africa

By Type
Amino Acids
Minerals
Vitamins
Lipids
Eubiotics
Enzymes
Carotenoids

By Application
Ruminants
Poultry
Aquaculture
Swine
Equine
Pets
Others

Table of Contents

1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Amino Acids
1.1.2.2 Minerals
1.1.2.3 Vitamins
1.1.2.4 Lipids
1.1.2.5 Eubiotics
1.1.2.6 Enzymes
1.1.2.7 Carotenoids
1.1.3 Market by Application
1.1.3.1 Ruminants
1.1.3.2 Poultry
1.1.3.3 Aquaculture
1.1.3.4 Swine
1.1.3.5 Equine
1.1.3.6 Pets
1.1.3.7 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 Market by Region
1.2.2.1 Asia-Pacific
1.2.2.2 North America
1.2.2.3 Europe
1.2.2.4 South America
1.2.2.5 Middle East & Africa

…..

6 Key Manufacturers
6.1 BASF
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Cargill
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Royal DSM
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Nutreco
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Evonik Industries
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Novozymes
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 DuPont
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Dow Chemical
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Alltech
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Kemin Industries
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Archer-Daniels-Midland
6.12 Adisseo France

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Vaginal Pessary Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2023

PUNE, MAHARASHTRA, INDIA, February 22, 2018 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Vaginal Pessary Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Vaginal Pessary Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Vaginal Pessary Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

a vaginal pessary is a removable device placed into the vagina. It is designed to support areas of pelvic organ prolapse.Vaginal pessaries can be broadly divided into two types: support and space-filling pessaries
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

Global Vaginal Pessary market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

By Company
CooperSurgical
MedGyn
Personal Medical Corp
Integra LifeSciences
Panpac Medical
Medesign
Smiths Medical
Thomas Medical
Kangge Medical
Dr. Arabin

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2741397-2015-2023-world-vaginal-pessary-market-research-report-by-product

Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)

By Type
Ring Pessary
Shelf Pessary

By End-User / Application
Mild Pelvic Organ Prolapse
Stress Urinary Incontinence
Severe Pelvic Organ Prolapse

Table of Contents

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

…..

12 Key Manufacturers
12.1 CooperSurgical
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 MedGyn
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 Personal Medical Corp
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 Integra LifeSciences
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 Panpac Medical
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Medesign
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Smiths Medical
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Thomas Medical
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Kangge Medical
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 Dr. Arabin
12.10.1 Company Overview
12.10.2 Product and End-User / Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Sexual Enhancement Supplements Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2023

PUNE, MAHARASHTRA, INDIA, February 22, 2018 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Sexual Enhancement Supplements Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Sexual Enhancement Supplements Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Sexual Enhancement Supplements Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Sexual Enhancement Supplements work by increasing the amount of blood flow the genital region receives and the volume of blood that it can retain.

Global Sexual Enhancement Supplements market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

By Company
Innovus Pharmaceuticals
Leading Edge Health
Direct Digital
SizeGenix
Vimax
Xanogen
Vydox
TEK Naturals

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2812307-global-sexual-enhancement-supplements-market-research-report-2018

Market Segment as follows:
By Region
Asia-Pacific (Segment by Company, Type and Application)
North America (Segment by Company, Type and Application)
Europe (Segment by Company, Type and Application)
South America (Segment by Company, Type and Application)
Middle East & Africa (Segment by Company, Type and Application)

By Type
Male Sexual Enhancement Supplements
Female Sexual Enhancement Supplements

By Application
Physical Stores
Online Stores

Table of Contents

1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Male Sexual Enhancement Supplements
1.1.2.2 Female Sexual Enhancement Supplements
1.1.3 Market by Application
1.1.3.1 Physical Stores
1.1.3.2 Online Stores
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 Market by Region
1.2.2.1 Asia-Pacific
1.2.2.2 North America
1.2.2.3 Europe
1.2.2.4 South America
1.2.2.5 Middle East & Africa

…..

6 Key Manufacturers
6.1 Innovus Pharmaceuticals
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Leading Edge Health
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Direct Digital
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 SizeGenix
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Vimax
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Xanogen
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Vydox
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 TEK Naturals
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Myocarditis Therapeutic Pipeline Market Review, H1 2018

Myocarditis Pharmaceutical and Healthcare Pipeline Review H1

PUNE , INDIA, February 22, 2018 /EINPresswire.com/ — Summary
Myocarditis is inflammation of the heart muscle. Myocarditis is an uncommon disorder that is usually caused by viral, bacterial, or fungal infections that reach the heart. Symptoms include chest pain, rapid or abnormal heartbeat, shortness of breath, at rest or during physical activity, fluid retention with swelling of legs, ankles and feet and fatigue. Treatment includes antibiotics, anti-inflammatory medicines to reduce swelling and diuretics to remove excess water from the body.

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Myocarditis – Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Myocarditis (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2989078-myocarditis-pipeline-review-h1-2018

The Myocarditis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocarditis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III and Preclinical stages are 1 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 3 molecules, respectively.

Myocarditis (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Myocarditis (Cardiovascular).
– The pipeline guide reviews pipeline therapeutics for Myocarditis (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Myocarditis (Cardiovascular) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Myocarditis (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Myocarditis (Cardiovascular)

Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Myocarditis (Cardiovascular).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Myocarditis (Cardiovascular) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Content: Key Points
List of Tables
List of Figures
Introduction
Myocarditis – Overview
Myocarditis – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Myocarditis – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Myocarditis – Companies Involved in Therapeutics Development
CEL-SCI Corp
Evotec AG
Swedish Orphan Biovitrum AB
Myocarditis – Drug Profiles
anakinra – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CEL-1000 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2989078-myocarditis-pipeline-review-h1-2018

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

US Ambulatory (ECG) Market Analysis 2018 (By Segment, Key Players and Applications) and Forecasts To 2022

US Ambulatory (ECG) Market 2018 Analysis, Opportunities and Forecast to 2022

PUNE , INDIA, February 22, 2018 /EINPresswire.com/ — The ambulatory ECG records the electrical activity of heart while walking (ambulatory) and doing normal activities. In contrast to the usual 12 lead ECG, where the heart’s electrical signals are captured for only a few seconds, the continuous ambulatory ECG monitor can record such signals over a prolonged period at the patient’s own home or work environment.

Ambulatory ECG monitoring, which can be performed using a variety of techniques for as short as 24 to 48 hours and for as long as months to years, offers the opportunity to review cardiac ECG data during normal routine activity, including any physical and psychological stresses. Ambulatory ECG monitoring for longer periods (when compared with standard ECG for a 10-second time period) is more sensitive for detecting spontaneous, often highly variable cardiac arrhythmias or conduction abnormalities. Current ambulatory ECG monitoring technologies include traditional holter, event monitors, mobile cardiac outpatient telemetry (MCOT) and implantable loop recorders.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3003076-us-ambulatory-electrocardiography-ecg-market-industry-analysis-outlook-2018-2022

The US ambulatory ECG market is set to experience favorable growth driven by factors such rising ageing population, increasing health care expenditure, accelerating economic growth, growing burden of atrial fibrillation and rise in prevalence of cardiovascular disorders. The major trends observed in this market include technological advancements, increased demand for home based monitoring systems product innovation- PocketECG. However, the growth of this budding is constrained by challenges such as high competition, stringent regulations and high barriers to entry.

The report “The US Ambulatory ECG Market: Industry Analysis & Outlook (2018-2022)” analyses the development of this market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: BioTelemetry, Inc., Koninklijke Philips N.V, iRhythm Technologies Inc. and Medtronic Plc. are being profiled along with their key financials and strategies for growth.

Table of Content: Key Points
1. Overview
2. The US Ambulatory ECG Market
3. Market Dynamics
4. Competitive Landscape
5. Company Profiles
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/3003076-us-ambulatory-electrocardiography-ecg-market-industry-analysis-outlook-2018-2022

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Hexamethylene Diisocyanate Industry: 2018 Global Market Size, Share, Trends, Key Manufacturers and 2023 Demand Forecast

Hexamethylene Diisocyanate Market Research Report 2018

2018-2023 World Hexamethylene Diisocyanate Market Research Report

Latest research report on “Global Hexamethylene Diisocyanate Market 2018 Research Report ” now available at a high quality database of OrianResearch.com

PUNE, MAHARASHTRA, INDIIA, February 22, 2018 /EINPresswire.com/ — The Global Hexamethylene Diisocyanate Market Report 2018 is a professional and in-depth study on the current state of the Hexamethylene Diisocyanate industry. The report provides a basic overview of the market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries.

The Hexamethylene Diisocyanate industry analysis is provided for the international markets including product types and end industries in global and major regions.

Get Sample Copy of this Report at – https://www.orianresearch.com/request-sample/459912 .

The report provides a basic critique of the industry including objective research, operations and industry upstream and downstream chain structure. The Hexamethylene Diisocyanate Market analysis is provided for the international market including development antiquity, cutthroat landscape scrutiny and key regions evolution stature.

Complete report on Hexamethylene Diisocyanate Market report spread across 118 pages, profiling 06 companies and supported with tables and figures available. Enquire more @ https://www.orianresearch.com/enquiry-before-buying/459912 .

Analysis of Hexamethylene Diisocyanate Market Key Companies –
• Vencorex
• Bayer
• BASF SE
• Asahi Kasei Corporation
• Tosoh
• WANHUA

This report focuses on Capacity, Sales Revenue, Volume, Price, Cost and Margin, as well as the each type price of key manufacturers, through interviewing key manufacturers.

On basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Hexamethylene Diisocyanate, revenue and market share, for key manufacturers.

Market Segment By Region / Countries this report covers:-
• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain etc)
• South America (Brazil, Argentina etc)
• Middle East & Africa (Saudi Arabia, South Africa etc)

Market Segment By Type this report covers:-
• Purity 99.9%
• Purity 99.5%
• Others

Market Segment By End-User / Application this report covers:-
• Paints
• Adhesive
• Others

The report spotlights on global major leading industry participants with information such as company portraits, product snaps and specification, scope, production, price, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s further, the worldwide Hexamethylene Diisocyanate industry development trends and marketing carriers are analysed.

With the list of tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Get Direct Copy of this Report @ https://www.orianresearch.com/checkout/459912 .

Major Points Covered in Table of Contents:
1 Market Definition
2 Global Market by Vendors
3 Global Market by Type
4 Global Market by End-Use / Application
5 Global Market by Regions
6 North America Market
7 Europe Market
8 Asia-Pacific Market
9 South America Market
10 Middle East & Africa Market
11 Market Forecast
12 Key Manufacturers
Research Conclusion
Data Source

Ruwin Mendez
OrianResearch Consultants
+1 832-380-8827
email us here


Source: EIN Presswire